Abstract: Vasculature closure devices, and systems and methods for their use, are provided. In one or more embodiments, a vasculature closure device (200) includes an expandable support frame (210) deployable within a vessel (10), and a sealing membrane (205) at least partially supported by the support frame (210). Upon expanding the support frame (210) within the vessel (10), the device is configured to intraluminally position the sealing membrane (205) against a puncture site existing in a wall of the vessel. The sealing membrane includes an area of excess membrane (245) configured to facilitate coupling of the sealing membrane to the wall of the vessel.
Type:
Grant
Filed:
July 14, 2014
Date of Patent:
October 2, 2018
Assignee:
E-Pacing, Inc.
Inventors:
Abraham Penner, Lone Wolinsky, Alon Ben-Yosef
Abstract: Vasculature closure devices, and systems and methods for their use, are provided. In one embodiment, the vasculature closure device includes an expandable support frame deployable within a vessel and a sealing membrane at least partially supported by the expandable support frame. Upon expanding the support frame, the vasculature closure device is configured to intraluminally position the sealing membrane against a puncture site existing in a vessel wall.
Type:
Grant
Filed:
August 9, 2010
Date of Patent:
September 30, 2014
Assignee:
E-Pacing, Inc.
Inventors:
Abraham Penner, Lone Wolinsky, Alon Ben-Yosef
Abstract: Medical devices, systems, and methods are provided for providing respiratory therapy by electrically stimulating the phrenic nerves and/or the thoracic diaphragm. In one embodiment, at least one electrode is deployed to a position within the patient's airway and placed in proximity to a phrenic nerve or to the diaphragm. The electrode may be attached to a controller housing including a pulse generator using one or more electrical lead or leads or may be in wireless communication with the pulse generator. The controller housing may be implanted at a position within the patient or the controller housing may reside external to the patient.
Abstract: An implantable system is provided for stimulation of the heart, phrenic nerve, or other tissue structures accessible via a patient's airway. The stimulation system includes an implantable controller housing which includes a pulse generator; at least one electrical lead attachable to said pulse generator; and at least one electrode carried by the at least one electrical lead, wherein the at least one electrode is positionable and fixable at a selected position within an airway of a patient. The controller housing may be adaptable for implantation subcutaneous, or alternatively, at a selected position within the patient's trachea or bronchus, wherein the controller housing is proportioned to substantially permit airflow through the patient's airway about housing.